PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
2016; American Association for the Advancement of Science; Volume: 8; Issue: 369 Linguagem: Inglês
10.1126/scitranslmed.aae0348
ISSN1946-6242
AutoresGrace R. Anderson, Suzanne E. Wardell, Merve Çakır, Lorin Crawford, Jim C. Leeds, Daniel P. Nussbaum, Pallavi S. Shankar, Ryan S. Soderquist, Elizabeth M. Stein, Jennifer P. Tingley, Peter Winter, Elizabeth K. Zieser-Misenheimer, Holly M. Alley, Alexander P. Yllanes, Victoria O. Haney, Kimberly Blackwell, Shannon J. McCall, Donald P. McDonnell, Kris C. Wood,
Tópico(s)Ubiquitin and proteasome pathways
ResumoInhibitors of BCL-X L , combined with inhibition of the mTOR/4E-BP axis, drive regressions of PIK3CA mutant breast tumors.
Referência(s)